MPhil/PhD, MD(Res), option of joint PhD with HKU
The research strategy of the division is to elucidate molecular, immunological and physiological mechanisms of asthma, allergy and related respiratory diseases, including COPD; to identify new therapeutic targets; to test new treatment modalities and to provide insights on the management of adult and paediatric patients with severe lung diseases, including respiratory failure.
The division focuses on basic mechanisms that underlie the genesis, propagation and sequelae of airways inflammation, an understanding of the mechanisms of anti-inflammatory drug action and management of the very ill patient at the bedside. The critical mass in the division creates a synergy not otherwise possible and offers opportunities for interactions while still preserving scientific independence.
The availability of shared knowledge, equipment, reagents and human materials (such as nasal or airway biopsies, cell lines and clones) provides an immensely valuable resource and the clinical/basic science interface is one of the keys to its success.